UNLABELLED: We applied the 2008 National Osteoporosis Foundation (NOF) Guidelines to Framingham Osteoporosis Study participants and found nearly one half of Caucasian postmenopausal women and one sixth of men aged 50 years and older would be recommended for osteoporosis treatment. Given the high proportion of persons recommended for treatment, NOF Guidelines may need to be re-evaluated with respect to budget impact. INTRODUCTION: Little is known about the public health impact of the NOF Guidelines. Therefore, we determined the proportion of US Caucasians recommended for treatment of osteoporosis according to NOF Guidelines (2003 and 2008). METHODS: One thousand nine hundred and forty-six postmenopausal women and 1,681 men aged > or =50 years from the Framingham Study with information on bone mineral density (1987-2001) were included. Information on clinical predictors was used to estimate the 10-year probability of hip and major osteoporotic fracture by FRAX (version 3.0). RESULTS: Overall proportion of women meeting treatment criterion was less when the 2008 NOF Guidelines were applied (41.1%) compared with 2003 Guidelines (47.8%). The proportion of women aged <65 years meeting treatment criterion was much less when applying 2008 Guidelines (23.1% in 2003, 8.3% in 2008), whereas the proportion of women aged >75 years increased slightly (78.3% in 2003, 86.0% in 2008). Seventeen percent of men aged > or =50 years met treatment criterion (2.5% aged 50-64 years, 49.8% aged >75 years). CONCLUSIONS: Nearly one half of Caucasian postmenopausal women and one sixth of men aged 50 years and older would be recommended for osteoporosis treatment according to 2008 NOF Guidelines. Given the high proportion of persons recommended for treatment, NOF Guidelines may need to be re-evaluated with respect to budget impact.
UNLABELLED: We applied the 2008 National Osteoporosis Foundation (NOF) Guidelines to Framingham Osteoporosis Study participants and found nearly one half of Caucasian postmenopausal women and one sixth of men aged 50 years and older would be recommended for osteoporosis treatment. Given the high proportion of persons recommended for treatment, NOF Guidelines may need to be re-evaluated with respect to budget impact. INTRODUCTION: Little is known about the public health impact of the NOF Guidelines. Therefore, we determined the proportion of US Caucasians recommended for treatment of osteoporosis according to NOF Guidelines (2003 and 2008). METHODS: One thousand nine hundred and forty-six postmenopausal women and 1,681 men aged > or =50 years from the Framingham Study with information on bone mineral density (1987-2001) were included. Information on clinical predictors was used to estimate the 10-year probability of hip and major osteoporotic fracture by FRAX (version 3.0). RESULTS: Overall proportion of women meeting treatment criterion was less when the 2008 NOF Guidelines were applied (41.1%) compared with 2003 Guidelines (47.8%). The proportion of women aged <65 years meeting treatment criterion was much less when applying 2008 Guidelines (23.1% in 2003, 8.3% in 2008), whereas the proportion of women aged >75 years increased slightly (78.3% in 2003, 86.0% in 2008). Seventeen percent of men aged > or =50 years met treatment criterion (2.5% aged 50-64 years, 49.8% aged >75 years). CONCLUSIONS: Nearly one half of Caucasian postmenopausal women and one sixth of men aged 50 years and older would be recommended for osteoporosis treatment according to 2008 NOF Guidelines. Given the high proportion of persons recommended for treatment, NOF Guidelines may need to be re-evaluated with respect to budget impact.
Authors: Amir Qaseem; Vincenza Snow; Paul Shekelle; Robert Hopkins; Mary Ann Forciea; Douglas K Owens Journal: Ann Intern Med Date: 2008-05-06 Impact factor: 25.391
Authors: Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson Journal: J Bone Miner Res Date: 2007-03 Impact factor: 6.741
Authors: Elizabeth J Samelson; Yuqing Zhang; Douglas P Kiel; Marian T Hannan; David T Felson Journal: Am J Public Health Date: 2002-05 Impact factor: 9.308
Authors: Elizabeth J Samelson; Marian T Hannan; Yuqing Zhang; Harry K Genant; David T Felson; Douglas P Kiel Journal: J Bone Miner Res Date: 2006-08 Impact factor: 6.741
Authors: Yuqing Zhang; Xinxin Guo; Richard Saitz; Daniel Levy; Emily Sartini; Jingbo Niu; R Curtis Ellison Journal: Am J Med Date: 2008-08 Impact factor: 4.965
Authors: Eugene V McCloskey; Sreekanth Vasireddy; Jane Threlkeld; Joanne Eastaugh; Ailsa Parry; Nicolas Bonnet; Monique Beneton; John A Kanis; Diane Charlesworth Journal: J Bone Miner Res Date: 2008-10 Impact factor: 6.741
Authors: Bruce Ettinger; Hau Liu; Terri Blackwell; Andrew R Hoffman; Kristine E Ensrud; Eric S Orwoll Journal: J Clin Densitom Date: 2012-03-21 Impact factor: 2.617
Authors: James A Southers; Jonathan N Bauman; David A Price; Paul S Humphries; Gayatri Balan; John F Sagal; Tristan S Maurer; Yan Zhang; Robert Oliver; Michael Herr; David R Healy; Mei Li; Brendon Kapinos; Gwendolyn D Fate; Keith A Riccardi; Vishwas M Paralkar; Thomas A Brown; Amit S Kalgutkar Journal: ACS Med Chem Lett Date: 2010-05-13 Impact factor: 4.345
Authors: Margaret L Gourlay; John S Preisser; Li-Yung Lui; Jane A Cauley; Kristine E Ensrud Journal: J Bone Miner Res Date: 2012-04 Impact factor: 6.741
Authors: Sarah D Berry; Robert R McLean; Marian T Hannan; L Adrienne Cupples; Douglas P Kiel Journal: J Am Geriatr Soc Date: 2014-11-29 Impact factor: 5.562
Authors: John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey Journal: Arch Osteoporos Date: 2016-07-27 Impact factor: 2.617